NANOABLATION
Latest round
- Series B
Last raised
- Feb 2025
Total raised
- Undisclosed
Investors
- 8
About NANOABLATION
Founded in 2014 and based in Hangzhou, China, NANOABLATION operates as a pulsed electric field technology provider that focuses on the application of electromagnetic technology in tumor treatment. Its production and R&D base is located in Hangzhou Future Technology Park. It acquired ISO13485 quality management system certification. It established the Provincial Key Laboratory of Pulsed Electric Field Technology Medical Transformation with the First Affiliated Hospital of Zhejiang University School of Medicine. The company has applied for nearly 200 patents and has PCT patents for the European and American markets. It has been recognized as Zhejiang Specialized, Refined, Featured and Original SMEs, Hangzhou Quasi-Unicorn Enterprise and Hangzhou Enterprise High-tech R&D Center. The company is mainly engaged in the research and development of electromagnetic tumor therapy. Products include nanosecond pulse tumor ablation system, digital psychological behavior assessment platform system, tumor treatment device, minimally invasive puncture electrode and other supporting medical devices. It has developed multiple product pipelines for tumors, atrial fibrillation, chronic brain diseases, etc. The company generates revenue by providing pulse tumor ablation system, digital psychological behavior assessment platform system and other supporting medical devices. The company will use the funds to advance the clinical trials and commercialization of a number of products developed based on the nanosecond pulsed electric field technology platform.
Who invested in NANOABLATION
8 investors across 4 rounds
See all investors in NANOABLATION
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about NANOABLATION
Who invested in NANOABLATION?
NANOABLATION has 8 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NANOABLATION raised?
NANOABLATION has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did NANOABLATION last raise money?
NANOABLATION's most recent round on record is a Series B, in Feb 2025.
What does NANOABLATION do?
Founded in 2014 and based in Hangzhou, China, NANOABLATION operates as a pulsed electric field technology provider that focuses on the application of electromagnetic technology in tumor treatment.
Where is NANOABLATION headquartered?
NANOABLATION is headquartered in Hangzhou, China.
Which VCs invest in companies like NANOABLATION?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back medical devices & equipment companies at NANOABLATION's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like NANOABLATION? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.